language_icon
EN
HI

Amanta Healthcare Share price

AMANTA

131.13

0.42 (-0.32%)
NSE
BSE
Last updated on 30 Apr, 2026 | 15:44 IST
Today's High

132.00

Today's Low

128.51

52 Week Low

92.00

52 Week High

154.40

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Amanta Healthcare Chart

Amanta Healthcare Share Key Metrics

Volume
37035.00
Market Cap
509.17 CR
LTQ@LTP
2@131.13
ATP
130.08
Var Margin
14.73 %
Circuit Range
105.24-157.86
Delivery %
63.55 %
Value
48.18 L
ASM/GSM
No
Market Lot
1

Summary

Amanta Healthcare share price stands at ₹131.13 at 30 Apr, 2026 | 15:44. The stock Amanta Healthcare intraday movement has stayed between ₹128.51 and ₹132.00, while on a 52-week basis it has fluctuated from ₹92.00 to ₹154.40.
In terms of trading activity, Amanta Healthcare has recorded a volume of 37035 shares. The Amanta Healthcare has a market cap of ₹38829351. The stock’s Average Traded Price (ATP) stands at ₹13008, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2, 13113.
The Amanta Healthcare operates within a circuit range of ₹105.24-157.86 – ₹105.24-157.86, with a Value of ₹48.18 L. The Delivery Percentage for the day is 63.55%. Additionally, Amanta Healthcare currently falls under the No framework, and trades with a market lot size of 1.

Amanta Healthcare Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

64.93

Sector P/B

3.52

Sec. Div. Yield

0.57

Amanta Healthcare Resistance and Support

Pivot 132.12

Resistance

First Resistance

134.24

Second Resistance

136.92

Third Resistance

139.04

Support

First Support

129.44

Second Support

127.32

Third Support

124.64

Amanta Healthcare Shareholding Pattern

View More
  • 2026-27
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

63.56%

Mutual Fund

3.99%

Insurance

0.05%

Foreign Institutional Investors

1.1%

Domestic Institutional Investors

7.2%

Retail

24.1%

Others

0%

Total Promoters
JUN '25
63.56%
SEP '25
63.56%
DEC '25
63.56%

Amanta Healthcare Corporate Actions

DateAgenda
2026-02-10Quarterly Results
2025-11-11Quarterly Results
2025-09-26Quarterly Results

Amanta Healthcare News

Amanta Healthcare Ltd - 544502 - Clarification Letter On Earlier Disclosure Submitted On April 18Th, 2026, Pursuant To SEBI (PIT) Regulations, 2015

Amanta Healthcare's promoter Shri Bhavesh Patel clarified the acquisition of 15,500 equity shares. This transaction increased his total holding to 6,326,544 shares, representing 16.29% of the total voting capital.
Apr 22 2026 17:04:00

Amanta Healthcare Limited

Amanta Healthcare Limited clarified that 15,500 shares purchased by Promoter Shri Bhavesh Patel on March 30, 2026, were credited to his demat account on April 17, 2026. This revised his total holding from 16.25% to 16.29% of the total voting capital.
Apr 22 2026 17:04:00

Amanta Healthcare Limited

Amanta Healthcare clarified that promoter Shri Bhavesh Patel acquired 13,300 equity shares, not 28,800, revising an earlier intimation. The discrepancy arose from technical reasons during the share transfer process. This adjustment results in the promoter's total holding being 16.25%.
Apr 18 2026 16:04:00

Amanta Healthcare Limited

Amanta Healthcare announced the resignation of Shri Vimal Shrimali, AVP – HR & Admin, effective April 16, 2026. He cited personal reasons for his departure from the company.
Apr 16 2026 14:04:00

Amanta Healthcare Ltd - 544502 - Announcement under Regulation 30 (LODR)-Change in Management

Amanta Healthcare announced the resignation of Shri Vimal Shrimali, AVP - HR & ADMIN, effective April 16, 2026. The company acknowledged his resignation, stating it was due to personal reasons.
Apr 16 2026 14:04:00

Amanta Healthcare Limited

Amanta Healthcare confirmed its promoters did not encumber any shares during FY2025-26. This disclosure assures stakeholders of unchanged promoter holding status as per SEBI SAST regulations.
Apr 10 2026 12:04:00

Amanta Healthcare Limited

Amanta Healthcare conducted an analyst and institutional investor meeting on April 7, 2026, at a site visit. During the interaction, only publicly available information was shared, with no Unpublished Price Sensitive Information (UPSI) being discussed.
Apr 09 2026 10:04:00

Amanta Healthcare Limited

Amanta Healthcare will host an analyst/institutional investors meeting on April 7, 2026. The event, taking place in Kheda, Gujarat, will include an in-person group meeting and a site visit for participants.
Apr 02 2026 17:04:00

Amanta Healthcare Ltd - 544502 - Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

Amanta Healthcare's promoters confirmed no encumbrance on their company shares/securities for FY2025-26. This disclosure complies with SEBI (SAST) Regulations, 2011, assuring investors of stable promoter holdings.
Apr 02 2026 14:04:00

Amanta Healthcare Limited

Amanta Healthcare promoter Shri Bhavesh Patel acquired 28,800 equity shares on March 27 and 30, 2026, through open market purchases. This transaction, valued at ₹28.18 lakh, increased his shareholding from 16.22% to 16.29%, signaling continued confidence.
Apr 01 2026 14:04:00
Read More

About Amanta Healthcare

NSE : 758909  
BSE : 544502  
ISIN : INE084K01015  

Our Company was originally incorporated on December 21 1994 as Marck Parenterals (India) Limited with RoC Gujarat at Ahmedabad by converting the existing Partnership firm “Marck Parenterals (India)” under Part IX of the Companies Act 1956 and received the Certificate for Commencement of Business on January 06 1995. The name of our Company was changed to “Marck Biosciences Limited” pursuant to a special resolution passed by our shareholders on October 29 2005 and a fresh certificate of incorporation issued by the Registrar of Companies Gujarat at Ahmedabad dated November 2 2005. Subsequently the name of our Company was changed to “Amanta Healthcare Limited” pursuant to a special resolution passed by our shareholders on June 12 2014 and a fresh certificate of incorporation dated June 24 2014 issued by the Registrar of Companies Gujarat at Ahmedabad.Major Events and Milestones:1994- Converted in a Public Limited Company1997- Started implementation of Large Volume Parenterals (LVP) project for Formulations Fluid Therapy & Irrigation Solution1998- Commencement of L-1 in Block A2002- Launched a specialised production line “LVP Line II” for the manufacture of Large Volume Parenterals in Kheda Gujarat2005- Launched a specialised production line “SVP Line I” for the manufacture of Small Volume Parenterals in Kheda Gujarat.2007- Added L-III Large Volume Parenterals Facility for 500 ml products in Block -A2008- Launched a specialised production line “SVP line II” for the manufacture of Small Volume Parenterals in Kheda Gujarat.- Approval from The National Pharmaceutical Control Bureau – Malaysia (a PIC member)2021- Launched a specialised production line “SteriPort -Debottlenecking”2023- Received WHO- GMP certification for Manufacturing facility at Kheda Gujarat2024- Got CE Mark Certification for Eye Wash Solutions- Manufacturing out of seven (7) active production lines including SVP and LVP- Granted permission to manufacture and market the product named Linezolid I.V. injection (Domestic)

Read More

Amanta Healthcare Management

NamePosition
Bhavesh PatelChairman & Managing Director
Nitin JainNon Executive Independent Director
View More

Amanta Healthcare Similar Stocks

No Data Found

Amanta Healthcare FAQs

The Buying Price of Amanta Healthcare share is 131.13 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Amanta Healthcare stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Amanta Healthcare, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Amanta Healthcare shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Amanta Healthcare shares is 0. Useful to assess the stock's value relative to its book value.

To assess Amanta Healthcare’s valuation compare Sector P/E, P/B which are 64.93 & 3.52 with sector averages, along with growth rates and financial metrics.

The Market Cap of Amanta Healthcare is 509.17 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Amanta Healthcare share price is 154.40 & 92.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Amanta Healthcare belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost